Feature | HRS | May 16, 2017

Heart Rhythm Society 2017 Late-Breaking Electrophysiology Trials

HRS presentations include data on the S-ICD, Micra, Nanostim, PV isolation, lead extractions and pharma

An electrophysiology EP ablation procedure to treat a heart arrhythmia

May 16, 2017 — Here is a list of the late-breaking clinical trials presented at the Heart Rhythm Society (HRS) 2017 annual meeting May 10-13, in Chicago. The data presented is for the latest in electrophysiology (EP) clinical research, techniques and technologies. These trials were featured at Heart Rhythm 2017 and will be published in the July issue of the Heart Rhythm Journal. 

Late-breaking Studies Presented at HRS 2017:

• The S-ICD Post-market Approval Study

Intra-nasal Etripamil For Conversion Of Paroxysmal Supraventricular Tachycardia (PSVT). Node-1 Trial

A Leadless Pacemaker In The Real-world Setting: The Micra Transcatheter Pacing System Post-approval Registry

• A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU (Apixaban Evaluation Of Interrupted Or Uninterrupted Anticoagulation For Ablation Of Atrial Fibrillation) Trial

• Long Detection Programming In Single Chamber Defibrillators Reduces Unnecessary Therapies And Mortality: The Advance III Trial

• EWOLUTION trial: 1-Year Efficacy and Safety of Left Atrial Appendage Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation

• SPECT-guided Left Ventricular Lead Placement For Improved CRT Efficacy: A Randomized Controlled Trial

• Ranolazine in High-Risk ICD Patients (RAID) Trial

• Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment In Subjects With Recurrent Atrial Fibrillation: Results From The Powder Af Multicentre Randomised Trial

High Incidence Of Previously Unknown (“Silent”) Atrial Fibrillation In Patients At High Risk For Atrial Fibrillation And Stroke: Primary Results From The REVEAL AF Study

• The Nanostim Leadless Pacemaker: Battery Failures and Worldwide Chronic Device Retrieval

Compliant Endovascular Balloon Reduces the Lethality of Superior Vena Cava Tears During Transvenous Lead Extractions

First-in-man Feasibility Study Of Subcutaneous Defibrillation Utilizing An Integrated Flexible String Shaped Defibrillator

PV Isolation With A Novel Multielectrode Radiofrequency Balloon Catheter That Allows Directionally-tailored Energy Delivery (RADIANCE): A Multicenter First-in-man Experience

 

Other Key Presentations:

Expert Consensus Released on Catheter, Surgical Ablation of Atrial Fibrillation

Expert Consensus on MRI and Radiation Exposure in Patients With Implantable Cardiac Electronic Devices

Watch the VIDEO "Current State of Atrial Fibrillation Technologies," an interview with Dr. Hugh Calkins at HRS 2017

Watch the VIDEO interview with HRS President Michael Gold, M.D., to hear about the latest EP technology trends that will be discussed at HRS 2017.

 

For more information: www.hrssessions.org

Related Content

News | Heart Failure| May 22, 2017
Serelaxin failed to meet the primary endpoints of the phase 3 RELAX-AHF-2 trial, according to late-breaking results...
Consumers Warned About Accuracy of Heart Rate Apps in New Study
News | Mobile Devices| May 22, 2017
May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability
Sponsored Content | Videos | Atrial Fibrillation| May 17, 2017
Hugh Calkins, M.D., FACC, FAHA, FHRS, director of cardiac arrhythmia services and professor of medicine at Johns Hopk
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems| May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Sponsored Content | Videos | EP Lab| May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Spectranetics Bridge Occlusion Balloon in the SVC

An illustration of how the Bridge balloon can seal the SVC after an accidental tear from lead extration.

Feature | EP Lab| May 17, 2017 | Dave Fornell
May 17, 2017 — A new intravenous occlusion balloon designed to seal any accidental tears in the superior vena cava (S
Early Treatment for NSTEMI Patients Shows Greater Rate of Survival
News | Cath Lab| May 16, 2017
An analysis of non ST-elevation myocardial infarction (NSTEMI) patients who undergo coronary revascularization within...
micra leadless pacemaker
Feature | Pacemakers| May 16, 2017
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Regist
Overlay Init